In summary, our results provide additional arguments supporting the thesis about the biological differences characterizing CML with different types of BCR::ABL1 gene transcripts and suggest that the BCR::ABL1 transcript type may play a critical role in the immunological and clinical outcomes of CML. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.